36 E. Mamounas - State of the Art: Individualzed decisions i...

36 E. Sloan - Repurposing beta-blockers for cancer

36 E. Χατζηχαρίση - MW κ Παθογένεια ΠΜ

36 F. Detterbeck - Lung cancer surgery in the 21st century.

36 I. Michalopoulou - Overview of the ethics and regulatory...

36 J. Nixon - Radiotherapy in Soft Tissue Sarcomas: principl...

36 M. Moschogianni - PARP inhibitors and myeloid malignancie...

36 M. Γκοτζαμανίδου - Ο αγώνας των νέων αναστολέων των οιστρ...

36 M. Δήμου - Θεραπεία 1ης γραμμής σε ασθενείς με ΟΜΛ με συν...

36 M. Μπαχλιτζανάκη - COVID-19 και ασθενείς με συμπαγείς όγκ...

36 Martin Hutchings - Bispecific Antibodies in the Treatment...

36 N. Tsoukalas - Future perspectives of FCO.

36 Nikolaos Nasis - Endovascular Management of Cerebral Vasc...

36 S. Kosta - Infrastructure and cybersecurity: what happens...

36 S. Rauh - Small molecule inhibitors against targetable ab...